Skip to main content
Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
959.41
+43.35 (4.73%)
At close: Nov 11, 2026, 4:00 PM EST
964.90
+5.49 (0.57%)
After-hours: Nov 11, 2026, 7:57 PM EST

Regeneron Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
96,27579,19376,63993,40377,05766,029
Market Cap Growth
39.91%3.33%-17.95%21.21%16.70%29.49%
Enterprise Value
80,12363,17061,05680,41466,76757,309
Last Close Price
959.41768.90705.67870.08714.75625.62

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
21.2417.5817.3723.6317.768.18
Forward PE
11.9317.1115.1919.3617.2911.00
PS Ratio
5.705.525.407.126.334.11
PB Ratio
2.872.532.613.603.403.52
P/TBV Ratio
2.992.642.723.753.543.52
P/FCF Ratio
25.1619.4120.9124.1017.4210.11
P/OCF Ratio
19.8715.9117.3420.3315.379.32
PEG Ratio
1.002.930.954.755.865.17

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
4.744.404.306.135.493.57
EV/EBITDA Ratio
14.1914.8813.1917.2812.516.18
EV/EBIT Ratio
15.6117.0614.7319.0013.376.37
EV/FCF Ratio
20.9415.4816.6620.7515.098.78

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.080.100.100.110.120.14
Debt / EBITDA Ratio
0.480.690.630.600.520.29
Debt / FCF Ratio
0.710.730.800.720.630.41
Net Debt / Equity Ratio
-0.48-0.51-0.51-0.52-0.51-0.52
Net Debt / EBITDA Ratio
-2.86-3.74-3.23-2.89-2.17-1.06
Net Debt / FCF Ratio
-4.22-3.89-4.09-3.47-2.61-1.51
Asset Turnover
0.400.370.400.420.450.76
Inventory Turnover
2.932.532.512.512.372.74
Quick Ratio
2.723.283.864.824.162.98
Current Ratio
3.354.134.735.695.063.56
Return on Equity (ROE)
14.95%14.87%15.95%16.26%20.94%54.21%
Return on Assets (ROA)
7.59%5.91%7.31%8.49%11.42%26.39%
Return on Invested Capital (ROIC)
16.31%13.04%18.58%22.38%26.65%60.13%
Return on Capital Employed (ROCE)
13.40%10.20%12.30%14.30%19.20%41.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
4.71%5.69%5.76%4.23%5.63%12.23%
FCF Yield
3.97%5.15%4.78%4.15%5.74%9.89%
Dividend Yield
0.39%0.46%----
Payout Ratio
8.32%8.22%----
Buyback Yield / Dilution
3.11%5.65%-1.23%-0.18%-1.16%2.52%
Total Shareholder Return
3.50%6.10%-1.23%-0.18%-1.16%2.52%
SEC Filings: 10-K · 10-Q